Mather Group LLC. Boosts Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Mather Group LLC. raised its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 3.6% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 786 shares of the biotechnology company’s stock after acquiring an additional 27 shares during the period. Mather Group LLC.’s holdings in Axon Enterprise were worth $467,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Commonwealth Financial Services LLC purchased a new position in Axon Enterprise during the fourth quarter worth about $212,000. WESPAC Advisors SoCal LLC grew its position in Axon Enterprise by 20.1% during the fourth quarter. WESPAC Advisors SoCal LLC now owns 3,418 shares of the biotechnology company’s stock worth $2,031,000 after buying an additional 573 shares in the last quarter. Financial Life Planners bought a new stake in Axon Enterprise during the fourth quarter worth about $480,000. Rice Partnership LLC lifted its stake in Axon Enterprise by 19.9% during the fourth quarter. Rice Partnership LLC now owns 602 shares of the biotechnology company’s stock worth $358,000 after purchasing an additional 100 shares during the last quarter. Finally, Chicago Capital LLC lifted its stake in Axon Enterprise by 8.2% during the fourth quarter. Chicago Capital LLC now owns 23,358 shares of the biotechnology company’s stock worth $13,882,000 after purchasing an additional 1,775 shares during the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares in the company, valued at approximately $4,185,601.03. This represents a 6.10 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Julie A. Cullivan sold 1,261 shares of the company’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total value of $860,077.66. Following the transaction, the director now owns 2,392 shares in the company, valued at $1,631,487.52. This trade represents a 34.52 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock valued at $30,721,337 in the last 90 days. Insiders own 5.70% of the company’s stock.

Axon Enterprise Trading Up 2.7 %

AXON opened at $680.52 on Thursday. The business has a 50 day simple moving average of $621.94 and a two-hundred day simple moving average of $490.00. The firm has a market capitalization of $51.89 billion, a price-to-earnings ratio of 175.85, a PEG ratio of 6.54 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a one year low of $255.58 and a one year high of $698.67.

Wall Street Analyst Weigh In

Several brokerages have issued reports on AXON. The Goldman Sachs Group lifted their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. TD Cowen began coverage on Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 price target for the company. Northland Securities lifted their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Finally, JMP Securities lifted their price target on Axon Enterprise from $610.00 to $725.00 and gave the stock a “market outperform” rating in a research note on Tuesday. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average target price of $542.15.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.